Skip to main content

Advertisement

SpringerLink
Log in

Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease

  • Review
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Data have accumulated to show that various types of collagen crosslinking are implicated in the health of individuals, as well as in a number of disease states, such as osteoporosis, diabetes mellitus, chronic kidney disease, inflammatory bowel disease, or in conditions of mild hyperhomocysteinemia, or when glucocorticoid use is indicated. Collagen crosslinking is a posttranslational modification of collagen molecules and plays important roles in tissue differentiation and in the mechanical properties of collagenous tissue. The crosslinking of collagen in the body can form via two mechanisms: one is enzymatic crosslinking and the other is nonenzymatic crosslinking. Lysyl hydroxylases and lysyl oxidases regulate tissue-specific crosslinking patterns and quantities. Enzymatic crosslinks initially form via immature divalent crosslinking, and a portion of them convert into mature trivalent forms such as pyridinoline and pyrrole crosslinks. Nonenzymatic crosslinks form as a result of reactions which create advanced glycation end products (AGEs), such as pentosidine and glucosepane. These types of crosslinks differ in terms of their mechanisms of formation and function. Impaired enzymatic crosslinking and/or an increase of AGEs have been proposed as a major cause of bone fragility associated with aging and numerous disease states. This review focuses on the effects of collagen crosslinking on bone material properties in health and disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Buckwalter JA, Glimcher MJ, Cooper RR, Recker R (1996) Bone biology, I: structure, blood supply, cells, matrix, and mineralization. Instr Course Lect 45:371–386

    CAS  PubMed  Google Scholar 

  2. Seeman E, Delmas PD (2006) Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med 354:2250–2261

    CAS  PubMed  Google Scholar 

  3. Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266–300

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Robins SP, Bailey AJ (1977) The chemistry of the collagen cross-links. Characterization of the products of reduction of skin, tendon and bone with sodium cyanoborohydride. Biochem J 163:339–346

    CAS  PubMed Central  PubMed  Google Scholar 

  5. Uzawa K, Grzesik WJ, Nishiura T, Kuznetsov SA, Robey PG, Brenner DA, Yamauchi M (1999) Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. J Bone Miner Res 14:1272–1280

    CAS  PubMed  Google Scholar 

  6. Saito M, Soshi S, Tanaka T, Fujii K (2004) Intensity-related differences in collagen post-translational modification in MC3T3-E1 osteoblasts after exposure to low and high intensity pulsed ultrasound. Bone 35:644–655

    CAS  PubMed  Google Scholar 

  7. Bank RA, Robins SP, Wijmenga C, Breslau-Siderius LJ, Bardoel AF, van der Sluijs HA, Pruijs HE, TeKoppele JM (1999) Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci USA 96:1054–1058

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Pornprasertsuk S, Duarte WR, Mochida Y, Yamauchi M (2005) Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J Bone Miner Res 20:81–87

    CAS  PubMed  Google Scholar 

  9. Saito M, Marumo K, Fujii K, Ishioka N (1997) Single column high—performance liquid chromatographic—fluorescence detection of immature, mature and senescent cross-links of collagen. Anal Biochem 253:26–32

    CAS  PubMed  Google Scholar 

  10. Saito M, Shiraishi A, Ito M, Sakai S, Hayakawa N, Mihara M, Marumo K (2010) Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model. Bone 46:1170–1179

    CAS  PubMed  Google Scholar 

  11. Eyre DR, Dickson IR, Ness KV (1988) Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem J 252:495–500

    CAS  PubMed Central  PubMed  Google Scholar 

  12. Knott L, Bailey AJ (1998) Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 22:181–187

    CAS  PubMed  Google Scholar 

  13. Saito M, Fujii K, Soshi S, Tanaka T (2006) Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17:986–995

    CAS  PubMed  Google Scholar 

  14. Saito M, Marumo K, Kida Y, Uhsiku C, Kato S, Takao-Kawabata R, Kuroda T (2011) Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1–34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys. Osteoporos Int 22:2373–2383

    CAS  PubMed  Google Scholar 

  15. Marumo K, Saito M, Yamagishi M, Fujii K (2005) The “ligamentization” process in human anterior cruciate ligament reconstruction with autogenous patellar and hamstring tendons. Am J Sports Med 33:1166–1173

    PubMed  Google Scholar 

  16. Yamauchi M, Katz EP (1993) The post-translational chemistry and molecular packing of mineralizing tendon collagens. Connect Tissue Res 29:81–98

    CAS  PubMed  Google Scholar 

  17. Fujii K, Yamagishi T, Nagafuchi T, Tsuji M, Kuboki Y (1994) Biochemical properties of collagen from ligaments and periarticular tendons of the human knee. Knee Surg Sports Traumatol Arthrosc 2:229–233

    CAS  PubMed  Google Scholar 

  18. Kato S, Saito M, Funasaki H, Marumo K (2013) Distinctive collagen maturation process in fibroblasts derived from rabbit anterior cruciate ligament, medial collateral ligament, and patellar tendon in vitro. Knee Surg Sports Traumatol Arthrosc. doi:10.1007/s00167-013-2773-8

    PubMed Central  Google Scholar 

  19. Yamauchi M, Katz EP, Mechanic GL (1986) Intermolecular cross-linking and stereospecific molecular packing in type I collagen fibrils of the periodontal ligament. Biochemistry 25:4907–4913

    CAS  PubMed  Google Scholar 

  20. Yamauchi M, Woodley DT, Mechanic GL (1988) Aging and cross-linking of skin collagen. Biochem Biophys Res Commun 152:898–903

    CAS  PubMed  Google Scholar 

  21. Yamauchi M, Shiiba M (2008) Lysine hydroxylation and cross-linking of collagen. Methods Mol Biol 446:95–108

    CAS  PubMed  Google Scholar 

  22. Yamauchi M, Sricholpech M (2012) Lysine post-translational modifications of collagen. Essays Biochem 52:113–133

    CAS  PubMed Central  PubMed  Google Scholar 

  23. Yeowell HN, Walker LC (1999) Tissue specificity of a new splice form of the human lysyl hydroxylase 2 gene. Matrix Biol 18:179–187

    CAS  PubMed  Google Scholar 

  24. Yeowell HN, Walker LC (2000) Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI. Mol Genet Metab 71:212–224

    CAS  PubMed  Google Scholar 

  25. Kuboki Y, Kudo A, Mizuno M, Kawamura M (1992) Time-dependent changes of collagen cross-links and their precursors in the culture of osteogenic cells. Calcif Tissue Int 50:473–480

    CAS  PubMed  Google Scholar 

  26. Bank RA, Bayliss MT, Lafeber FP, Maroudas A, Tekoppele JM (1998) Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. Biochem J 330:345–351

    CAS  PubMed Central  PubMed  Google Scholar 

  27. Rivera EM, Yamauchi M (1993) Site comparisons of dentine collagen cross-links from extracted human teeth. Arch Oral Biol 38:541–546

    CAS  PubMed  Google Scholar 

  28. Miguez PA, Pereira PN, Atsawasuwan P, Yamauchi M (2004) Collagen cross-linking and ultimate tensile strength in dentin. J Dent Res 83:807–810

    CAS  PubMed  Google Scholar 

  29. Hayashi M, Furuya Y, Minoshima K, Saito M, Marumo K, Nakashima S, Hongo C, Kim J, Ota T, Ebisu S (2012) Effects of heating on the mechanical and chemical properties of human dentin. Dent Mater 28:385–391

    CAS  PubMed  Google Scholar 

  30. Saito M, Soshi S, Fujii K (2003) Effect of hyper- and microgravity on collagen post-translational controls of MC3T3-E1 osteoblasts. J Bone Miner Res 18:1695–1705

    CAS  PubMed  Google Scholar 

  31. Gerstenfeld LC, Riva A, Hodgens K, Eyre DR, Landis WJ (1993) Post-translational control of collagen fibrillogenesis in mineralizing cultures of chick osteoblasts. J Bone Miner Res 8:1031–1043

    CAS  PubMed  Google Scholar 

  32. Eyre DR, Paz A, Gallop PM (1984) Cross-linking in collagen and elastin. Annu Rrev Biochem 53:717–748

    CAS  Google Scholar 

  33. Bird TA, Levene CI (1982) Lysyl oxidase: evidence that pyridoxal phosphate is a co-factor. Biochem Biophys Res Commun 108:1172–1180

    CAS  PubMed  Google Scholar 

  34. Wang SX, Mure M, Medzihradszky KF, Burlingame AL, Brown DE, Dooley DM, Smith AJ, Kagan HM, Klinman JP (1996) A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science 273:1078–1084

    CAS  PubMed  Google Scholar 

  35. Fujii K, Kajiwara T, Kurosu H (1979) Effect of vitamin B6 deficiency on the crosslink formation of collagen. FEBS Lett 97:193–195

    CAS  PubMed  Google Scholar 

  36. Satio M, Fujii K, Mori Y, Marumo K (2006) Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 17:1514–1523

    Google Scholar 

  37. Feres-Filho EJ, Choi YJ, Han X, Takala TE, Trackman PC (1995) Pre- and post-translational regulation of lysyl oxidase by transforming growth factor-beta 1 in osteoblastic MC3T3-E1 cells. J Biol Chem 270:30797–30803

    CAS  PubMed  Google Scholar 

  38. Hong HH, Uzel MI, Duan C, Sheff MC, Trackman PC (1999) Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest 79:1655–1667

    CAS  PubMed  Google Scholar 

  39. Reiser K, Summers P, Medrano JF, Rucker R, Last J, McDonald R (1996) Effects of elevated circulating IGF-1 on the extracellular matrix in high-growth C57BL/6J mice. Am J Physiol 271:R696–R703

    CAS  PubMed  Google Scholar 

  40. Ozasa H, Tominaga T, Nishimura T, Takeda T (1981) Lysyl oxidase activity in the mouse uterine cervix is physiologically regulated by estrogen. Endocrinology 109:618–621

    CAS  PubMed  Google Scholar 

  41. Nagaoka H, Mochida Y, Atsawasuwan P, Kaku M, Kondoh T, Yamauchi M (2008) 1,25(OH)2D3 regulates collagen quality in an osteoblastic cell culture system. Biochem Biophys Res Commun 377:674–678

    CAS  PubMed  Google Scholar 

  42. Raposo B, Rodriguez C, Martinez-Gonzalez J, Badimon L (2004) High levels of homocysteine inhibit lysyl oxidase (LOX) and down regulate LOX expression in vascular endothelial cells. Atherosclerosis 177:1–8

    CAS  PubMed  Google Scholar 

  43. Liu G, Nellaiappan K, Kagan HM (1997) Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 272:32370–32377

    CAS  PubMed  Google Scholar 

  44. Kang HA, Trelstad RL (1973) A collagen defect in homocystinuria. J Clin Invest 52:2571–2578

    CAS  PubMed Central  PubMed  Google Scholar 

  45. Saito M, Fujii K, Marumo K (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 79:160–168

    CAS  PubMed  Google Scholar 

  46. Blouin S, Thaler HW, Korninger C, Schmid R, Hofstaetter JG, Zoehrer R, Phipps R, Klaushofer K, Roschger P, Paschalis EP (2009) Bone matrix quality and plasma homocysteine levels. Bone 44:959–964

    CAS  PubMed  Google Scholar 

  47. Feres-Filho EJ, Menassa GB, Trackman PC (1996) Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells. J Biol Chem 271:6411–6416

    CAS  PubMed  Google Scholar 

  48. Boak AM, Roy R, Berk J, Taylor L, Polgar P, Goldstein RH, Kagan HM (1994) Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-b1 and prostaglandin E2. Am J Respir Cell Mol Biol 11:751–755

    CAS  PubMed  Google Scholar 

  49. Rodriguez C, Alcudia JF, Martinez-Gonzalez J, Raposo B, Navarro MA, Badimon L (2008) Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction. Atherosclerosis 196:558–564

    CAS  PubMed  Google Scholar 

  50. Turecek C, Fratzl-Zelman N, Rumpler M (2008) Collagen cross-linking influences osteoblastic differentiation. Calcif Tissue Int 82:392–400

    CAS  PubMed  Google Scholar 

  51. Fernandes H, Dechering K, Van Someren E, Steeghs I, Apotheker M, Leusink A, Bank R, Janeczek K, Van Blitterswijk C, de Boer J (2009) The role of collagen crosslinking in differentiation of human mesenchymal stem cells and MC3T3-E1 cells. Tissue Eng Part A 15:3857–3867

    CAS  PubMed  Google Scholar 

  52. Eyre DR, Paz A, Gallop PM (1984) Cross-linking in collagen and elastin. Annu Rev Biochem 53:717–748

    CAS  PubMed  Google Scholar 

  53. Fujii K, Kuboki Y, Sasaki S (1976) Aging of human bone and cartilage collagen: changes in the reducible cross-links and their precursors. Gerontology 22:363–370

    CAS  PubMed  Google Scholar 

  54. Bailey AJ, Shimokomaki MS (1971) Age related changes in the reducible cross-links of collagen. FEBS Lett 16:86–88

    CAS  PubMed  Google Scholar 

  55. Robins SP, Shimokomaki M, Bailey AJ (1973) Age-related changes in the reducible components of intact bovine collagen fibres. Biochem J 131:771–780

    CAS  PubMed Central  PubMed  Google Scholar 

  56. Ogawa T, Ono T, Tsuda M (1982) A novel fluor in insoluble collagen: a crosslinking moiety in collagen molecule. Biochem Biophys Res Commun 107:1252–1257

    CAS  PubMed  Google Scholar 

  57. Eyre DR, Oguchi H (1980) The hydroxypyridinium crosslinks of collagens: their measurement, properties and a proposed pathway of formation. Biochem Biophys Res Commun 92:403–410

    CAS  PubMed  Google Scholar 

  58. Robins SP, Duncan A (1987) Pyridinium crosslinks of bone collagen and their location in peptides isolated from rat femur. Biochim Biophys Acta 914:233–239

    CAS  PubMed  Google Scholar 

  59. Robins SP, Duncan A (1983) Cross-linking of collagen. Location of pyridinoline in bovine articular cartilage at two sites of the molecule. Biochem J 215:175–182

    CAS  PubMed Central  PubMed  Google Scholar 

  60. Brady JD, Robins SP (2001) Structural characterization of pyrrolic cross-links in collagen using a biotinylated Ehrlich’s reagent. J Biol Chem 276:18812–18818

    CAS  PubMed  Google Scholar 

  61. Kuypers R, Tyler M, Kurth LB, Jenkins ID, Horgan DJ (1992) Identification of the loci of the collagen-associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem J 283:129–136

    CAS  PubMed Central  PubMed  Google Scholar 

  62. Hanson DA, Eyre DR (1996) Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem 271:26508–26516

    CAS  PubMed  Google Scholar 

  63. Banse X, Devogelaer JP, Lafosse A, Sims TJ, Grynpas M, Bailey AJ (1998) Cross-link profile of bone collagen correlates with structural organization of trabeculae. Bone 31:70–76

    Google Scholar 

  64. Wang X, Shen X, Li X, Agrawal CM (2002) Age-related changes in the collagen network and toughness of bone. Bone 31:1–7

    PubMed  Google Scholar 

  65. Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML, Christiansen C, Delmas PD (2006) Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 38:300–309

    CAS  PubMed  Google Scholar 

  66. Oxlund H, Mosekilde L, Ortoft G (1996) Reduced concentration of collagen reducible crosslinks in human trabecular bone with respect to age and osteoporosis. Bone 19:479–484

    CAS  PubMed  Google Scholar 

  67. Saito M, Marumo K, Ushiku C, Kato S, Sakai S, Hayakawa N, Mihara M, Shiraishi A (2011) Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats. Calcif Tissue Int 88:314–324

    CAS  PubMed  Google Scholar 

  68. Yamauchi M, Shiiba M (2008) Lysine hydroxylation and cross-linking of collagen. Methods Mol Biol 446:95–108

    CAS  PubMed  Google Scholar 

  69. Robins SP (1982) Analysis of the crosslinking components in collagen and elastin. Methods Biochem Anal 28:329–379

    CAS  PubMed  Google Scholar 

  70. Avery NC, Sims TJ, Bailey AJ (2009) Quantitative determination of collagen cross-links. Methods Mol Biol 522:103–121

    CAS  PubMed  Google Scholar 

  71. Gineyts E, Borel O, Chapurlat R, Garnero P (2010) Quantification of immature and mature collagen crosslinks by liquid chromatography-electrospray ionization mass spectrometry in connective tissues. J Chromatogr B Analyt Technol Biomed Life Sci 878:1449–1454

    CAS  PubMed  Google Scholar 

  72. Takahashi M, Hoshino H, Kushida K, Inoue T (1995) Direct measurement of crosslinks, pyridinoline, deoxypyridinoline, and pentosidine, in the hydrolysate of tissues using high-performance liquid chromatography. Anal Biochem 232:158–162

    CAS  PubMed  Google Scholar 

  73. Viguet-Carrin S, Gineyts E, Bertholon C (2009) Simple and sensitive method for quantification of fluorescent enzymatic mature and senescent crosslinks of collagen in bone hydrolysate using single-column high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 877:1–7

    CAS  PubMed  Google Scholar 

  74. Bank RA, Beekman B, Verzijl N, de Roos JA, Sakkee AN, TeKoppele JM (1997) Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run. J Chromatogr B Biomed Sci Appl 703:37–44

    CAS  PubMed  Google Scholar 

  75. Banse X, Sims TJ, Bailey AJ (2002) Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res 17:1621–1628

    CAS  PubMed  Google Scholar 

  76. Farlay D, Duclos ME, Gineyts E, Bertholon C, Viguet-Carrin S, Nallala J, Sockalingum GD, Bertrand D, Roger T, Hartmann DJ, Chapurlat R, Boivin G (2011) The ratio 1660/1690 cm−1 measured by infrared microspectroscopy is not specific of enzymatic collagen cross-links in bone tissue. PLoS One 6:e28736

    CAS  PubMed Central  PubMed  Google Scholar 

  77. Gourion-Arsiquaud S, Lukashova L, Power J, Loveridge N, Reeve J, Boskey AL (2013) Fourier transform infrared imaging of femoral neck bone: reduced heterogeneity of mineral-to-matrix and carbonate-to-phosphate and more variable crystallinity in treatment-naive fracture cases compared with fracture-free controls. J Bone Miner Res 28:150–161

    CAS  PubMed Central  PubMed  Google Scholar 

  78. Satio M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195–214

    Google Scholar 

  79. Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, Ibrahim SA (1992) Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41(Suppl 2):36–41

    CAS  PubMed  Google Scholar 

  80. Robins SP, Bailey AJ (1972) Age-related changes in collagen: the identification of reducible lysine-carbohydrate condensation products. Biochem Biophys Res Commun 48:76–84

    CAS  PubMed  Google Scholar 

  81. Nagai R, Shirakawa J, Fujiwara Y, Ohno R, Moroishi N, Sakata N, Nagai M (2014) Detection of AGEs as markers for carbohydrate metabolism and protein denaturation. J Clin Biochem Nutr 55:1–6

    CAS  PubMed Central  PubMed  Google Scholar 

  82. Monnier VM, Sell DR, Dai Z, Nemet I, Collard F, Zhang J (2008) The role of the amadori product in the complications of diabetes. Ann N Y Acad Sci 1126:81–88

    CAS  PubMed  Google Scholar 

  83. Beisswenger PJ, Howell S, Mackenzie T, Corstjens H, Muizzuddin N, Matsui MS (2012) Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes. Diabetes Technol Ther 14:285–292

    CAS  PubMed  Google Scholar 

  84. Couppé C, Hansen P, Kongsgaard M, Kovanen V, Suetta C, Aagaard P, Kjaer M, Magnusson SP (1985) Mechanical properties and collagen cross-linking of the patellar tendon in old and young men. J Appl Physiol 107:880–886

    Google Scholar 

  85. Nakamura K, Nakazawa Y, Ienaga K (1997) Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. Biochem Biophys Res Commun 232:227–230

    CAS  PubMed  Google Scholar 

  86. Sims TJ, Rasmussen LM, Oxlund H, Bailey AJ (1996) The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 39:946–951

    CAS  PubMed  Google Scholar 

  87. Sell DR, Biemel KM, Reihl O, Lederer MO, Strauch CM, Monnier VM (2005) Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 280:12310–12315

    CAS  PubMed  Google Scholar 

  88. Karim L, Tang SY, Sroga GE, Vashishth D (2013) Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone. Osteoporos Int 24:2441–2447

    CAS  PubMed  Google Scholar 

  89. Saito M, Grynpas MD, Burr DB, Allen MR, Smith SY, Doyle N, Amizuka N, Hasegawa T, Kida Y, Marumo K, Saito H (2014) Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone. Bone 73:8–15. doi:10.1016/j.bone.2014.11.025

    PubMed  Google Scholar 

  90. Willett TL, Sutty S, Gaspar A, Avery N, Grynpas M (2013) In vitro non-enzymatic ribation reduces post-yield strain accommodation in cortical bone. Bone 52:611–622

    PubMed  Google Scholar 

  91. Saito M, Mori S, Mashiba T, Komatsubara S, Marumo K (2008) Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs. Osteoporos Int 19:1343–1354

    CAS  PubMed  Google Scholar 

  92. Silva MJ, Brodt MD, Lynch MA, McKenzie JA, Tanouye KM, Nyman JS, Wang X (2009) Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth and diminished whole-bone strength and fatigue life. J Bone Miner Res 24:1618–1627

    CAS  PubMed Central  PubMed  Google Scholar 

  93. Viguet-Carrin S, Roux JP, Arlot ME, Merabet Z, Leeming DJ, Byrjalsen I, Delmas PD, Bouxsein ML (2006) Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 39:1073–1079

    CAS  PubMed  Google Scholar 

  94. Biemel KM, Reihl O, Conrad J, Lederer MO (2001) Formation pathways for lysine-arginine cross-links derived from hexoses and pentoses by Maillard processes: unraveling the structure of a pentosidine precursor. J Biol Chem 276:23405–23412

    CAS  PubMed  Google Scholar 

  95. Brennan M (1989) Changes in solubility, non-enzymatic glycation, and fluorescence of collagen in tail tendons from diabetic rats. J Biol Chem 264:20852–20947

    Google Scholar 

  96. Saito M (1999) Age-related changes in biochemical characteristics of collagen from human weight-bearing and non-weight-bearing bone. Tokyo Jikeikai Med J 114:327–337. http://sciencelinks.jp/j-east/article/200010/000020001000A0286989.php

  97. Sanguineti R, Storace D, Monacelli F, Federici A, Odetti P (2008) Pentosidine effects on human osteoblasts in vitro. Ann N Y Acad Sci 1126:166–172

    CAS  PubMed  Google Scholar 

  98. Ogawa N, Yamaguchi T, Yano T, Yamauchi M, Yamamoto M, Sugimoto T (2007) The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm Metab Res 39:871–875

    CAS  PubMed  Google Scholar 

  99. Mercer N, Ahmed H, Etcheverry SB, Vasta GR, Cortizo AM (2007) Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells. Mol Cell Biochem 306:87–94

    CAS  PubMed  Google Scholar 

  100. Cortizo AM, Lettieri MG, Barrio DA, Mercer N, Etcheverry SB, McCarthy AD (2003) Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Mol Cell Biochem 250:1–10

    CAS  PubMed  Google Scholar 

  101. Khosravi R, Sodek KL, Faibish M, Trackman PC (2014) Collagen advanced glycation inhibits its Discoidin Domain Receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts. Bone 58:33–41

    CAS  PubMed  Google Scholar 

  102. Zhou Z, Han JY, Xi CX, Xie JX, Feng X, Wang CY, Mei L, Xiong WC (2008) HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE. J Bone Miner Res 23:1084–1096

    CAS  PubMed Central  PubMed  Google Scholar 

  103. Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K, Taketomi S (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol 8:260–270

    CAS  PubMed  Google Scholar 

  104. Mitome J, Yamamoto H, Saito M, Yokoyama K, Marumo K, Hosoya T (2011) Non-enzymatic crosslinking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients. Calcif Tissue Int 88:521–529

    CAS  PubMed  Google Scholar 

  105. Valcourt U, Merle B, Gineyts E, Viguet-Carrin S, Delmas PD, Garnero P (2007) Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem 282:5691–5703

    CAS  PubMed  Google Scholar 

  106. Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Y, Hata K, Fukumoto S, Matsumoto T (1997) Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 82:2915–2920

    CAS  PubMed  Google Scholar 

  107. Tang SY, Allen MR, Phipps R, Burr DB, Vashishth D (2009) Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int 20:887–894

    CAS  PubMed Central  PubMed  Google Scholar 

  108. Allen MR, Gineyts E, Leeming DJ, Burr DB, Delmas PD (2008) Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. Osteoporos Int 19:329–337

    CAS  PubMed  Google Scholar 

  109. McCarthy AD, Etcheverry SB, Bruzzone L, Lettieri G, Barrio DA, Cortizo AM (2001) Non-enzymatic glycation of a type I collagen matrix: effect on osteoblastic development and oxidative stress. BMC Cell Biol 2:16

    CAS  PubMed Central  PubMed  Google Scholar 

  110. Nojiri H, Saita Y, Morikawa D, Kobayashi K, Tsuda C, Miyazaki T, Saito M, Marumo K, Yonezawa I, Kaneko K, Shirasawa T, Shimizu T (2011) Cytoplasmic superoxide causes bone fragility due to low turnover osteoporosis with impaired collagen cross-links. J Bone Miner Res 26:2682–2694

    CAS  PubMed  Google Scholar 

  111. Derouiche F, Bôle-Feysot C, Naïmi D, Coëffier M (2014) Hyperhomocysteinemia-induced oxidative stress differentially alters proteasome composition and activities in heart and aorta. Biochem Biophys Res Commun 452:740–745

    CAS  PubMed  Google Scholar 

  112. Saito M, Marumo K, Soshi S, Kida Y, Ushiku C, Shinohara A (2010) Raloxifene ameliorates detrimental enzymatic and non-enzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int 21:655–666

    CAS  PubMed  Google Scholar 

  113. Miyata T, de Strihou CVY, Kurokawa K, Baynes JW (1999) Alterations in nonenzymatic biochemistry in uremia: origin and significance of “carbonyl stress” in long-term uremic complications. Kidney Int 55:389–399

    CAS  PubMed  Google Scholar 

  114. Kalninova J, Jakus V, Glejtkova M, Kuracka L, Sandorova E (2014) Impact of glycemic control on advanced glycation and inflammation in overweight and obese patients with type 2 diabetes mellitus. Bratisl Lek Listy 115:457–468

    CAS  PubMed  Google Scholar 

  115. Okazaki K, Yamaguchi T, Tanaka K, Notsu M, Ogawa N, Yano S, Sugimoto T (2012) Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis. Calcif Tissue Int 91:286–296

    CAS  PubMed  Google Scholar 

  116. McNerny EM, Gong B, Morris MD, Kohn DH (2014) Bone fracture toughness and strength correlate with collagen cross-link maturity in a dose-controlled lathyrism mouse model. J Bone Miner Res. doi:10.1002/jbmr.2356

    Google Scholar 

  117. Oxlund H, Barckman M, Ortoft G, Andreassen TT (1995) Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone 17:365S–371S

    CAS  PubMed  Google Scholar 

  118. Opsahl W, Zeronian H, Ellison M, Lewis D, Rucker RB, Riggins RS (1982) Role of copper in collagen cross-linking and its influence on selected mechanical properties of chick bone and tendon. J Nutr 112:708–716

    CAS  PubMed  Google Scholar 

  119. Knott L, Whitehead CC, Fleming RH, Bailey AJ (1995) Biochemical changes in the collagenous matrix of osteoporotic avian bone. Biochem J 310:1045–1051

    CAS  PubMed Central  PubMed  Google Scholar 

  120. Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S, Saga Y, Fukayama M, Sata M, Kudo A (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205:295–303

    CAS  PubMed Central  PubMed  Google Scholar 

  121. Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A (2010) Incorporaiton of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 285:2028–2039

    CAS  PubMed Central  PubMed  Google Scholar 

  122. Maruhashi T, Kii I, Saito M, Kudo A (2010) Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem 85:13294–13303

    Google Scholar 

  123. Mochida Y, Parisuthiman D, Pornprasertsuk-Damrongsri S, Atsawasuwan P, Sricholpech M, Boskey AL, Yamauchi M (2009) Decorin modulates collagen matrix assembly and mineralization. Matrix Biol 28:44–52

    CAS  PubMed Central  PubMed  Google Scholar 

  124. Parisuthiman D, Mochida Y, Duarte WR, Yamauchi M (2005) Biglycan modulates osteoblast differentiation and matrix mineralization. J Bone Miner Res 20:1878–1886

    CAS  PubMed  Google Scholar 

  125. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP (2001) Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 28:195–201

    CAS  PubMed  Google Scholar 

  126. Tang SY, Zeenath U, Vashishth D (2007) Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40:1144–1151

    CAS  PubMed Central  PubMed  Google Scholar 

  127. Nyman JS, Roy A, Acuna RL, Gayle HJ, Reyes MJ, Tyler JH, Dean DD, Wang X (2006) Age-related effect on the concentration of collagen crosslinks in human osteonal and interstitial bone tissue. Bone 39:1210–1217

    CAS  PubMed Central  PubMed  Google Scholar 

  128. Nyman JS, Roy A, Tyler JH, Acuna RL, Gayle HJ, Wang X (2007) Age-related factors affecting the postyield energy dissipation of human cortical bone. J Orthop Res 25:646–655

    PubMed Central  PubMed  Google Scholar 

  129. Zioupos P, Currey JD, Hamer AJ (1999) The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res 45:108–116

    CAS  PubMed  Google Scholar 

  130. Dequeker J, Merlevede W (1971) Collagen content and collagen extractability pattern of adult human trabecular bone according to age, sex and amount of bone mass. Biochim Biophys Acta 244:410–420

    CAS  PubMed  Google Scholar 

  131. Bailey AJ, Sims TJ, Ebbesen EN (1999) Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int 65:203–210

    CAS  PubMed  Google Scholar 

  132. Odetti P, Rossi S, Monacelli F, Poggi A, Cirnigliaro M, Federici M, Federici A (2005) Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci 1043:710–717

    CAS  PubMed  Google Scholar 

  133. van der Harst MR, DeGroot J, Kiers GH, Brama PA, van de Lest CH, van Weeren PR (2005) Biochemical analysis of the articular cartilage and subchondral and trabecular bone of the metacarpophalangeal joint of horses with early osteoarthritis. Am J Vet Res 66:1238–1246

    PubMed  Google Scholar 

  134. van den Bos T, Speijer D, Bank RA, Brömme D, Everts V (2008) Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: special emphasis on collagen. Bone 43:459–468

    PubMed  Google Scholar 

  135. Matsuura T, Tokutomi K, Sasaki M, Katafuchi M, Mizumachi E, Sato H (2014) Distinct characteristics of mandibular bone collagen relative to long bone collagen: relevance to clinical dentistry. Biomed Res Int. doi:10.1155/2014/769414

    Google Scholar 

  136. Isaksson H, Tolvanen V, Finnilä MA, Iivarinen J, Tuukkanen J, Seppänen K, Arokoski JP, Brama PA, Jurvelin JS (2009) Helminen HJ.Physical exercise improves properties of bone and its collagen network in growing and maturing mice. Calcif Tissue Int 85:247–256

    CAS  PubMed  Google Scholar 

  137. Bailey AJ, Wotton SF, Sims TJ, Thompson PW (1993) Biochemical changes in the collagen of human osteoporotic bone matrix. Connect Tissue Res 29:119–132

    CAS  PubMed  Google Scholar 

  138. Aoki C, Uto K, Honda K, Kato Y, Oda H (2013) Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy. Lab Invest 93:1170–1183

    CAS  PubMed  Google Scholar 

  139. Gamsjaeger S, Srivastava AK, Wergedal JE, Zwerina J, Klaushofer K, Paschalis EP, Tatakis DN (2014) Altered bone material properties in HLA-B27 rats include reduced mineral to matrix ratio and altered collagen cross-links. J Bone Miner Res 29:2382–2391

    CAS  PubMed  Google Scholar 

  140. Guerra RC, Zuñiga-Muñoz A, Guarner Lans V, Díaz-Díaz E, TenaBetancourt CA, Pérez-Torres I (2014) Modulation of the activities of catalase, Cu–Zn, Mn superoxide dismutase, and glutathione peroxidase in adipocyte from ovariectomised female rats with metabolic syndrome. Int J Endocrinol. doi:10.1155/2014/175080

    PubMed Central  PubMed  Google Scholar 

  141. Ventura E, Durant R, Jaussent A, Picot MC, Morena M, Badiou S, Dupuy AM, Jeandel C, Cristol JP (2009) Homocysteine and inflammation as main determinants of oxidative stress in the elderly. Free Radic Biol Med 46:737–744

    CAS  PubMed  Google Scholar 

  142. Shiraki M, Urano T, Kuroda T, Saito M, Tanaka S, Miyao-Koshizuka M, Inoue S (2008) The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fracture. J Bone Miner Metab 26:595–602

    CAS  PubMed  Google Scholar 

  143. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042–2049

    CAS  PubMed  Google Scholar 

  144. Yang J, Hu X, Zhang Q, Cao H, Wang J, Liu B (2012) Homocysteine level and risk of fracture: a meta-analysis and systematic review. Bone 51:376–382

    CAS  PubMed  Google Scholar 

  145. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH (1996) Evidence for McKusick’s hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 13:159–162

    Google Scholar 

  146. Herrmann M, Tami A, Wildemann B, Wolny M, Wagner A, Schorr H, Taban-Shomal O, Umanskaya N, Ross S, Garcia P, Hübner U, Herrmann W (2008) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44:467–475

    PubMed  Google Scholar 

  147. Leslie WD, Rubin MR, Schwarz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Miner Res 27:2231–2237

    PubMed  Google Scholar 

  148. Hammond MA, Gallant MA, Burr DB, Wallace JM (2014) Nanoscale changes in collagen are reflected in physical and mechanical properties of bone at the microscale in diabetic rats. Bone 60:26–32

    CAS  PubMed Central  PubMed  Google Scholar 

  149. Tomasek JJ, Meyers SW, Basinger JB, Green DT, Shew RL (1994) Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats. Life Sci 55:855–861

    CAS  PubMed  Google Scholar 

  150. Ebesunun MO, Obajobi EO (2012) Elevated plasma homocysteine in type2 diabetes mellitus :a risk factor for cardiovascular diseases. Pan Afr Med J 12:48

    PubMed Central  PubMed  Google Scholar 

  151. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412

    CAS  PubMed  Google Scholar 

  152. Miller PD (2014) Bone disease in CKD: a focus on osteoporosis diagnosis and management. Am J Kidney Dis 64:290–304

    PubMed  Google Scholar 

  153. Kazama JJ, Iwasaki Y, Fukagawa M (2013) Uremic osteoporosis. Kidney Int Suppl (2011) 3:446–450

    CAS  Google Scholar 

  154. LowryMB Lotinun S, Leontovich AA, Zhang M, Maran A, Shogren KL, Palama BK, Marley K, Iwaniec UT, Turner RT (2008) Osteitis fibrosa is, mediated by platelet-derived growth factor-A via a phosphoinositide, 3-kinase-dependent signaling pathway in a rat model for chronic, hyperparathyroidism. Endocrinology 149:5735–5746

    Google Scholar 

  155. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J (2004) The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140:9–17

    PubMed  Google Scholar 

  156. Kaji H, Yamauchi M, Yamaguchi T, Shigematsu T, Sugimoto T (2010) Mild renal dysfunction is a risk factor for a decrease in bone mineral density and vertebral fractures in Japanese postmenopausal women. J Clin Endocrinol Metab 95:4635–4642

    CAS  PubMed  Google Scholar 

  157. LaCroix AZ, Lee JS, Wu L, Cauley JA, Shlipak MG, Ott SM, Robbins J, Curb JD, Leboff M, Bauer DC, Jackson RD, Kooperberg CL, Cummings SR (2008) Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc 56:1434–1441

    PubMed Central  PubMed  Google Scholar 

  158. Oussalah A, Guéant JL, Peyrin-Biroulet L (2011) Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 34:1173–1184

    CAS  PubMed  Google Scholar 

  159. Krajcovicova A, Hlavaty T, Killinger Z, Miznerova E, Toth J, Letkovsky J, Nevidanska M, Cierny D, Koller T, Zelinkova Z, Huorka M, Payer J (2014) Combination therapy with an immunomodulator and anti-TNF α agent improves bone mineral density in IBD patients. J Crohns Colitis. doi:10.1016/j.crohns.2014.08.004

    PubMed  Google Scholar 

  160. van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224–3229

    PubMed  Google Scholar 

  161. Canalis E (2005) Mechanisms of glucocorticoid action in bone. Curr Osteoporos Rep 3:98–102

    PubMed  Google Scholar 

  162. Yao W, Cheng Z, Pham A, Busse C, Zimmermann EA, Ritchie RO, Lane NE (2008) Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum 58:3485–3497

    CAS  PubMed Central  PubMed  Google Scholar 

  163. Saito M, Marumo K, Ushiku C, Kato S, Sakai S, Hayakawa N, Mihara M, Shiraishi A (2011) Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats. Calcif Tissue Int 88:314–324

    CAS  PubMed  Google Scholar 

  164. Benson SC, LuValle PA (1998) Inhibition of lysyl oxidase and prolyl hydroxylase activity in glucocorticoid treated rats. Biochem Biophys Res Commun 99:557–562

    Google Scholar 

  165. Centrella M, McCarthy TL, Canalis E (1991) Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 11:4490–4496

    CAS  PubMed Central  PubMed  Google Scholar 

  166. Delany AM, Durant D, Canalis E (2001) Glucocorticoid suppression of IGF I transcription in osteoblasts. Mol Endocrinol 15:1781–1789

    CAS  PubMed  Google Scholar 

  167. Reiser K, Summers P, Medrano JF, Rucker R, Last J, McDonald R (1996) Effects of elevated circulating IGF-1 on the extracellular matrix in high-growth C57BL/6J mice. Am J Physiol 271:R696–703

    CAS  PubMed  Google Scholar 

  168. Gallant MA, Brown DM, Hammond M, Wallace JM, Du J, Deymier-Black AC, Almer JD, Stock SR, Allen MR, Burr DB (2014) Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties. Bone 61:191–200

    CAS  PubMed Central  PubMed  Google Scholar 

  169. Saito M, Fujii K, Soshi S (2005) Effects of vitamin B6 and Vitamin K2 on bone mechanical properties and collagen cross-links in spontaneously diabetic WBN/Kob rats. J Bone Miner Res 20:S286

    Google Scholar 

  170. Ahmad S, Shahab U, Baig MH, Khan MS, Khan MS, Srivastava AK, Saeed M (2013) Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products. PLoS One 8:e72128

    CAS  PubMed Central  PubMed  Google Scholar 

  171. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88:11555–11558

    CAS  PubMed Central  PubMed  Google Scholar 

  172. Khatami M, Suldan Z, David I, Li W, Rockey JH (1988) Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation. Life Sci 43:1725–1731

    CAS  PubMed  Google Scholar 

  173. Voziyan PA, Hudson BG (2005) Pyridoxamine: the many virtues of a maillard reaction inhibitor. Ann N Y Acad Sci 1043:807–816

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

Mitsuru Saito and Keishi Marumo have no conflict of interest.

Human and Animal Rights and Informed Consent

All research, discussed in this review has been subject to ethics approval and, informed consent has been obtained in animal and human studies.

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, Tokyo, 105-8461, Japan

    Mitsuru Saito & Keishi Marumo

Authors
  1. Mitsuru Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keishi Marumo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuru Saito.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saito, M., Marumo, K. Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease. Calcif Tissue Int 97, 242–261 (2015). https://doi.org/10.1007/s00223-015-9985-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-015-9985-5

Keywords

Search

Navigation